All-Purpose Nanostrategy Based on Dose Deposition Enhancement, Cell Cycle Arrest, DNA Damage, and ROS Production as Prostate Cancer Radiosensitizer for Potential Clinical Translation

Scientists proposed an ‘all-purpose’ nanostrategy based on dose deposition enhancement, cell cycle arrest, and ROS production as prostate cancer radiosensitizer for potential clinical translation.